"Inflammation Mediators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The endogenous compounds that mediate inflammation (AUTACOIDS) and related exogenous compounds including the synthetic prostaglandins (PROSTAGLANDINS, SYNTHETIC).
| Descriptor ID |
D018836
|
| MeSH Number(s) |
D23.469
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammation Mediators".
Below are MeSH descriptors whose meaning is more specific than "Inflammation Mediators".
This graph shows the total number of publications written about "Inflammation Mediators" by people in this website by year, and whether "Inflammation Mediators" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 3 | 3 | 6 |
| 2004 | 3 | 2 | 5 |
| 2005 | 3 | 0 | 3 |
| 2006 | 2 | 2 | 4 |
| 2007 | 4 | 0 | 4 |
| 2008 | 1 | 6 | 7 |
| 2009 | 3 | 4 | 7 |
| 2010 | 4 | 2 | 6 |
| 2011 | 6 | 8 | 14 |
| 2012 | 4 | 3 | 7 |
| 2013 | 6 | 13 | 19 |
| 2014 | 5 | 10 | 15 |
| 2015 | 1 | 8 | 9 |
| 2016 | 2 | 8 | 10 |
| 2017 | 1 | 14 | 15 |
| 2018 | 3 | 5 | 8 |
| 2019 | 4 | 6 | 10 |
| 2020 | 4 | 5 | 9 |
| 2021 | 2 | 5 | 7 |
| 2022 | 0 | 2 | 2 |
| 2024 | 3 | 0 | 3 |
| 2025 | 1 | 0 | 1 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Inflammation Mediators" by people in Profiles.
-
Erythrocyte adenosine A2B receptor prevents cognitive and auditory dysfunction by promoting hypoxic and metabolic reprogramming. PLoS Biol. 2021 06; 19(6):e3001239.
-
a7-Acetylcholine Receptor Signaling Reduces Neuroinflammation After Subarachnoid Hemorrhage in Mice. Neurotherapeutics. 2021 07; 18(3):1891-1904.
-
Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Postoperative Atrial Fibrillation. Circ Res. 2020 09 25; 127(8):1036-1055.
-
Fibrosis and Inflammatory Markers and Long-Term Risk of Peripheral Artery Disease: The ARIC Study. Arterioscler Thromb Vasc Biol. 2020 09; 40(9):2322-2331.
-
Aspirin Modifies Inflammatory Mediators and Metabolomic Profiles and Contributes to the Suppression of Obesity-Associated Breast Cancer Cell Growth. Int J Mol Sci. 2020 Jun 30; 21(13).
-
A Moderate-Fat Diet with One Avocado per Day Increases Plasma Antioxidants and Decreases the Oxidation of Small, Dense LDL in Adults with Overweight and Obesity: A Randomized Controlled Trial. J Nutr. 2020 02 01; 150(2):276-284.
-
Dairy Intake and Body Composition and Cardiometabolic Traits among Adults: Mendelian Randomization Analysis of 182041 Individuals from 18 Studies. Clin Chem. 2019 06; 65(6):751-760.
-
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease. Contemp Clin Trials. 2019 04; 79:98-103.
-
IL-27 signaling deficiency develops Th17-enhanced Th2-dominant inflammation in murine allergic conjunctivitis model. Allergy. 2019 05; 74(5):910-921.
-
Importance of Toll-like Receptors in Pro-inflammatory and Anti-inflammatory Responses by Helicobacter pylori Infection. Curr Top Microbiol Immunol. 2019; 421:139-158.